To the Editor: In their recent article,1 Balit et al concluded "restriction of paracetamol-containing products may inadvertently increase poisoning with potentially more toxic agents". As manufacturers of one brand of ibuprofen tablets and the only brand of ibuprofen suspension in Australia, we would like to comment on the article and its conclusion.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- 1 Department of Social Medicine, Canynge Hall, Bristol, UK.
- 2 Boots Healthcare Australia Pty Ltd, North Ryde, NSW.
Correspondence: d.j.gunnell@bristol.ac.uk
Online responses are no longer available. Please refer to our instructions for authors page for more information.